Open-Label Placebo for Functional Dyspepsia

Overview

The study is evaluating the efficacy of open-label placebo for the treatment of functional dyspepsia.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 31, 2020

Interventions

  • Drug: Placebos
    • placebo pills

Arms, Groups and Cohorts

  • Experimental: open-label placebo
    • open-label placebo
  • No Intervention: treatment as usual

Clinical Trial Outcome Measures

Primary Measures

  • dyspepsia severity on a VAS from 0-100
    • Time Frame: 3 weeks
    • How severe have your dyspepsia symptoms been over the past 7 days (on a VAS from 0-100)?

Participating in This Clinical Trial

Inclusion Criteria

  • Functional Dyspepsia

Exclusion Criteria

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Beth Israel Deaconess Medical Center
  • Provider of Information About this Clinical Study
    • Principal Investigator: Judy Nee, Assistant Professor of Medicine – Beth Israel Deaconess Medical Center
  • Overall Contact(s)
    • Vivian Cheng, 6176670682, vcheng2@bidmc.harvard.edu

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.